Clever Leaves Holdings Inc (CLVR)
1.540
-0.02
(-1.57%)
USD |
NASDAQ |
May 01, 16:00
1.55
+0.01
(+0.62%)
After-Hours: 07:03
Clever Leaves Holdings Free Cash Flow (Quarterly): -1.387M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.387M |
| September 30, 2023 | -2.309M |
| June 30, 2023 | -1.731M |
| March 31, 2023 | -6.112M |
| December 31, 2022 | -4.547M |
| September 30, 2022 | -5.64M |
| June 30, 2022 | -8.599M |
| March 31, 2022 | -11.59M |
| Date | Value |
|---|---|
| December 31, 2021 | -9.37M |
| September 30, 2021 | -10.33M |
| June 30, 2021 | -10.97M |
| March 31, 2021 | -12.84M |
| December 31, 2020 | -4.061M |
| September 30, 2020 | -3.586M |
| June 30, 2020 | -9.103M |
| March 31, 2020 | -8.876M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-12.84M
Minimum
Mar 2021
-1.387M
Maximum
Dec 2023
-6.941M
Average
-7.356M
Median
Free Cash Flow (Quarterly) Benchmarks
| Tilray Brands Inc | -24.89M |
| Flora Growth Corp | -1.164M |
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |